Big Pharma Leverages Early-Stage Risk with Innovative Options

Article

In recent years, large pharmaceutical companies have launched a variety of initiatives to restock ailing pipelines and boost business performance including mergers and acquisitions, diversifying business portfolios to non-pharmaceutical products, downsizing, spinoffs, and entering the biopharmaceutical arena.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Recent Videos
Preeya Beczek, managing director and co-founder of Beczek.COM, chats about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Kate Coleman, vice president regulatory affairs, quality and compliance, Arriello, chats about industry trends and technological advances.
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

New Cancer Research and Treatment Center in Development in London

Susan Haigney
May 1st 2025
Article

Aviva Capital Partners and developer Socius are investing £1 billion in a 12-acre site to be located at the London Cancer Hub next to The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust’s Sutton site.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
September 27th 2024
Podcast

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Image Credit: © Tiero - stock.adobe.com

Biotherapeutics Partnerships and Innovation Expanding

Patrick Lavery
April 28th 2025
Article

Groundbreaking clinical studies and new research collaborations are pushing ahead even as uncertainty lingers about the geopolitical climate’s impact on development.

Site Logo

Vaccines and Virus Purification through the Ages

June 11th 2018
Podcast

Learn Morewww.bio-rad.com/fluvaccine

Genetic Code | Image Credit: © kentoh - © kentoh - Stock.adobe.com

Emerging Modalities and Strategic Innovation in the Biopharma R&D Landscape

Feliza Mirasol
April 28th 2025
Article

The biopharmaceutical landscape is undergoing a huge shift from traditional therapies to more specialty-driven modalities.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

CN Bio and Pharmaron Partner to Develop OOC Technologies for Global R&D

Feliza Mirasol
April 26th 2025
Article

Through the collaboration, Pharmaron will validate and promote the application of CN Bio’s PhysioMimix technology with plans to integrate OOC technologies into its R&D platform.

© 2025 MJH Life Sciences

All rights reserved.